(redirected from Canada's Research-Based Pharmaceutical Companies)
CRBPCCanada's Research-Based Pharmaceutical Companies
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Canada's Research-Based Pharmaceutical Companies (Rx&D) association welcomes the federal government's plan to renew Canada's regulatory system, This renewed initiative, under the Smart Regulation Report on Action and Plans, highlights three areas of importance to patients, physicians, health care stakeholders, and the research-based pharmaceutical community in Canada: the timeliness, efficiency, and transparency of the drug review process; the exercise of greater vigilance regarding the safety and therapeutic effectiveness of products currently on the market: and access by Canadians to appropriately prescribed and cost-effective drug therapies.
Nevertheless, the humanitarian gesture underlying the Act is being applauded by many, including the industry organizations representing Canada's research-based pharmaceutical companies (Rx&D) and Canada's generic drug industry (The Canadian Generic Pharmaceutical Association).
Canada's research-based pharmaceutical companies were represented by Nelle-Dominique Willems, director of federal government relations at Bristol-Myers Squibb Canada.
Canada's Research-Based Pharmaceutical Companies (R**&D) positions itself further as a key player in Canada's Innovation Agenda, with a $1 .1318 investment in Canadian R**&D last year alone.
Full browser ?